Cargando…

FOXM1 Modulates Cisplatin Sensitivity by Regulating EXO1 in Ovarian Cancer

Cisplatin is commonly used in ovarian cancer chemotherapy, however, chemoresistance to cisplatin remains a great clinical challenge. Oncogenic transcriptional factor FOXM1 has been reported to be overexpressed in ovarian cancer. In this study, we aimed to investigate the potential role of FOXM1 in o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Jinhua, Wang, Yunfei, Wang, You, Yin, Xia, He, Yifeng, Chen, Lilan, Wang, Wenwen, Liu, Ting, Di, Wen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019642/ https://www.ncbi.nlm.nih.gov/pubmed/24824601 http://dx.doi.org/10.1371/journal.pone.0096989

Ejemplares similares

BKM120 sensitizes BRCA-proficient triple negative breast cancer cells to olaparib through regulating FOXM1 and Exo1 expression
por: Li, Yu, et al.
Publicado: (2021)

Succinate dehydrogenase subunit B inhibits the AMPK-HIF-1α pathway in human ovarian cancer in vitro
por: Chen, Lilan, et al.
Publicado: (2014)

Cadmium chloride enhances cisplatin sensitivity in osteosarcoma cells by reducing FOXM1 expression
por: Hu, Konghe, et al.
Publicado: (2020)

Citrate Synthase Expression Affects Tumor Phenotype and Drug Resistance in Human Ovarian Carcinoma
por: Chen, Lilan, et al.
Publicado: (2014)

Deregulation of Exo70 Facilitates Innate and Acquired Cisplatin Resistance in Epithelial Ovarian Cancer by Promoting Cisplatin Efflux
por: Zhao, Yujie, et al.
Publicado: (2021)

Significant association of the EXO1 rs851797 polymorphism with clinical outcome of ovarian cancer
por: Shi, Tingyan, et al.
Publicado: (2017)

FOXM1-Mediated LINC-ROR Regulates the Proliferation and Sensitivity to Sorafenib in Hepatocellular Carcinoma
por: Zhi, Yingru, et al.
Publicado: (2019)

Cancer cell line specific co-factors modulate the FOXM1 cistrome
por: Wang, Yue, et al.
Publicado: (2017)

FOXM1 modulates 5-fluorouracil sensitivity in cholangiocarcinoma through thymidylate synthase (TYMS): implications of FOXM1–TYMS axis uncoupling in 5-FU resistance
por: Intuyod, Kitti, et al.
Publicado: (2018)

FoxM1 is Upregulated in Osteosarcoma and Inhibition of FoxM1 Decreases Osteosarcoma Cell Proliferation, Migration, and Invasion
por: Zhu, Xia, et al.
Publicado: (2020)

Downregulation of FoxM1 sensitizes nasopharyngeal carcinoma cells to cisplatin via inhibition of MRN-ATM-mediated DNA repair
por: Li, Dandan, et al.
Publicado: (2019)

STAT1-mediated inhibition of FOXM1 enhances gemcitabine sensitivity in pancreatic cancer
por: Liu, Chao, et al.
Publicado: (2019)

FOXM1: Functional Roles of FOXM1 in Non-Malignant Diseases
por: Zhang, Zhenwang, et al.
Publicado: (2023)

Interfering with the expression of EEF1D gene enhances the sensitivity of ovarian cancer cells to cisplatin
por: Xu, Qia, et al.
Publicado: (2022)

FOLR1 increases sensitivity to cisplatin treatment in ovarian cancer cells
por: Huang, Ming-ju, et al.
Publicado: (2018)

Sensitive and Label-free Detection of Bacteria in Osteomyelitis through Exo III-Assisted Cascade Signal Amplification
por: Li, Yuanyuan, et al.
Publicado: (2021)

Retraction Note to: FOXM1 modulates 5-fluorouracil sensitivity in cholangiocarcinoma through thymidylate synthase (TYMS): implications of FOXM1–TYMS axis uncoupling in 5-FU resistance
por: Intuyod, Kitti, et al.
Publicado: (2021)

Upregulation of FOXM1 leads to diminished drug sensitivity in myeloma
por: Gu, Chunyan, et al.
Publicado: (2018)

Nuclear COMMD1 Is Associated with Cisplatin Sensitivity in Ovarian Cancer
por: Fedoseienko, Alina, et al.
Publicado: (2016)

IDO1 Modulates the Sensitivity of Epithelial Ovarian Cancer Cells to Cisplatin through ROS/p53-Dependent Apoptosis
por: Wang, Houmei, et al.
Publicado: (2022)

m(6)A Methyltransferase KIAA1429 Regulates the Cisplatin Sensitivity of Gastric Cancer Cells via Stabilizing FOXM1 mRNA
por: Zhu, Zhongcheng, et al.
Publicado: (2022)

Exo-Functionalized Metallacages as Host-Guest Systems for the Anticancer Drug Cisplatin
por: Woods, Ben, et al.
Publicado: (2019)

Correction to: Upregulation of FOXM1 leads to diminished drug sensitivity in myeloma
por: Gu, Chunyan, et al.
Publicado: (2019)

Effect of taxol on the expression of FoxM1 ovarian cancer-associated gene
por: LIU, ZENG, et al.
Publicado: (2016)

FOXM1: A Multifunctional Oncoprotein and Emerging Therapeutic Target in Ovarian Cancer
por: Liu, Cassie, et al.
Publicado: (2021)

NAC1 Modulates Sensitivity of Ovarian Cancer Cells to Cisplatin via Altering the HMGB1-Mediated Autophagic Response
por: Zhang, Yi, et al.
Publicado: (2011)

MicroRNA-7 Inhibits Tumor Metastasis and Reverses Epithelial-Mesenchymal Transition through AKT/ERK1/2 Inactivation by Targeting EGFR in Epithelial Ovarian Cancer
por: Zhou, Xingchen, et al.
Publicado: (2014)

BET Bromodomain Inhibition as a Therapeutic Strategy in Ovarian Cancer by Downregulating FoxM1
por: Zhang, Zhenfeng, et al.
Publicado: (2016)

MMB-FOXM1-driven premature mitosis is required for CHK1 inhibitor sensitivity
por: Branigan, Timothy B., et al.
Publicado: (2021)

Overexpressed FOXM1 collaborates with MMB to increase WEE1 inhibitor sensitivity in NSCLC
por: Tan, Jian, et al.
Publicado: (2023)

Prognostic significance of FOXM1 expression and antitumor effect of FOXM1 inhibition in synovial sarcomas
por: Maekawa, Akira, et al.
Publicado: (2016)

FOXM1 Regulated by ERK Pathway MediatesTGF-β1-Induced EMT in NSCLC
por: Kong, Fei-Fei, et al.
Publicado: (2014)

Checkpoint-dependent phosphorylation of Exo1 modulates the DNA damage response
por: Morin, Isabelle, et al.
Publicado: (2008)

OTUB1-catalyzed deubiquitination of FOXM1 facilitates tumor progression and predicts a poor prognosis in ovarian cancer
por: Wang, Yiqin, et al.
Publicado: (2016)

The multifaceted roles of FOXM1 in pulmonary disease
por: Li, Yumei, et al.
Publicado: (2019)

FOXM1 modulates docetaxel resistance in prostate cancer by regulating KIF20A
por: Yu, Hongbo, et al.
Publicado: (2020)

Tripterygium glycosides sensitizes cisplatin chemotherapeutic potency by modulating gut microbiota in epithelial ovarian cancer
por: Zhan, Xinlu, et al.
Publicado: (2023)

Plant immunity suppression by an exo-β-1,3-glucanase and an elongation factor 1α of the rice blast fungus
por: Liu, Hang, et al.
Publicado: (2023)

Overexpression of FOXM1 is associated with metastases of nasopharyngeal carcinoma
por: Jiang, Lizhu, et al.
Publicado: (2014)

Increased FOXM1 Expression by Cisplatin Inhibits Paclitaxel-Related Apoptosis in Cisplatin-Resistant Human Oral Squamous Cell Carcinoma (OSCC) Cell Lines
por: Choi, Hyeong Sim, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3l3gorp86lrmgt9afv8s2v8tih